Page 83 - Squarepoint Ops News Today

Braze (NASDAQ:BRZE – Get Rating) had its price target raised by JPMorgan Chase & Co. from $36.00 to $40.00 in a research report released on Friday, The Fly reports. Several other brokerages have also recently issued reports on BRZE. Scotiabank assumed coverage on shares of Braze in a research note on Wednesday, May 17th. They […]

Shares of Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) have received an average rating of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price […]

Shares of Adient plc (NYSE:ADNT – Get Rating) have been assigned an average recommendation of “Hold” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and three have assigned a buy recommendation to the company. […]

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) has earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target […]

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating)’s share price gapped up prior to trading on Tuesday after an insider bought additional shares in the company. The stock had previously closed at $12.54, but opened at $13.00. Day One Biopharmaceuticals shares last traded at $13.56, with a volume of 197,640 shares changing hands. Specifically, CEO […]

Leggett & Platt, Incorporated (NYSE:LEG – Get Rating) declared a quarterly dividend on Thursday, May 4th, RTT News reports. Stockholders of record on Thursday, June 15th will be given a dividend of 0.46 per share on Friday, July 14th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 5.95%. The […]

Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) gapped down prior to trading on Tuesday . The stock had previously closed at $12.09, but opened at $11.74. Stoke Therapeutics shares last traded at $12.31, with a volume of 18,538 shares traded. Analyst Ratings Changes A number of brokerages have recently weighed in on STOK. […]

Arteris, Inc. (NASDAQ:AIP – Get Rating) CEO K Charles Janac sold 13,764 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $7.04, for a total value of $96,898.56. Following the completion of the sale, the chief executive officer now owns 243,188 […]

Shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the ten research firms that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month […]

FibroGen, Inc. (NASDAQ:FGEN – Get Rating) Director James A. Schoeneck sold 7,100 shares of the stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $18.03, for a total value of $128,013.00. Following the sale, the director now owns 73,722 shares of the company’s stock, valued at approximately […]